BioVeda China Fund III

2014
Healthcare
China
a case study about 
Healthcare 
in China

BioVeda China Fund III

2014
 | Healthcare
 | China
BioVeda China Fund III: 
a case study about 
Healthcare 
in China

In 2005, BioVeda China Fund (BVCF) Management Ltd became the first private equity firm specialized and dedicated to China’s healthcare and life sciences industries. BVCF supports Chinese entrepreneurs who are active in the development of innovative and affordable pharmaceutical products and services, and have a global scope. SIFEM invested in BVCF’s third fund, BVCF III, in 2014.

Links

Investment details: 
Company details: 

Latest News

As Jörg Frieden steps down after eight years as Chair of SIFEM’s Board of Directors, and Mirjam Staub-Bisang takes up the role, the outgoing and incoming chairs sit down together to reflect on impact, conviction, and the business of putting capital to good use.

Latest News

As Jörg Frieden steps down after eight years as Chair of SIFEM’s Board of Directors, and Mirjam Staub-Bisang takes up the role, the outgoing and incoming chairs sit down together to reflect on impact, conviction, and the business of putting capital to good use.